Ultra-low-dose naltrexone reduces the rewarding potency of oxycodone and relapse vulnerability in rats.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/3ADE2775.svg?ark=w1%2F20260515%2F3ADE2775)](https://nobleid.org/work/w1/20260515/3ADE2775)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors